And on to another fight... this time over ObamaCare protections. Bipartisan governors group denounces Trump on pre-existing conditions. The bipartisan governors group that has teamed up on health care in the past is back, this time calling for the Trump administration to reverse course on arguing against pre-existing condition protections in court. "The administration's disappointing decision to no longer defend this provision of federal law threatens health care coverage for many in our states with pre-existing conditions and adds uncertainty and higher costs for Americans who purchase their own health insurance," the governors said. Who joined the statement?: Govs. John Hickenlooper (D-Colo.), John Kasich (R-Ohio), Bill Walker (I-Alaska), Tom Wolf (D-Pa.), Brian Sandoval (R-Nev.), Steve Bullock (D-Mont.), Larry Hogan (R-Md.), Jay Inslee (D-Wash.), and Roy Cooper (D-N.C.). 2020 angle: Several of the governors are seen as potential presidential candidates, including Kasich, a Republican who has been critical of Trump. Kasich and Hickenlooper have teamed up on bipartisan health care proposals in recent months. Democrats seizing on the issue: Democrats are early bringing up the issue in midterm campaigns. The latest example? On Monday Sen. Bill Nelson (D-Fla.) held an event with people with pre-existing conditions. Nelson is in a tough race for reelection against Florida Gov. Rick Scott (R). More on the governors' stance here Congress is trying to tackle the opioid epidemic as deaths from the crisis are mounting. But will lawmakers' efforts help? Many public health advocates applaud the House's effort, while some say there's still more work to be done to curb an epidemic that sees an estimated 115 Americans dying per day of an opioid-related overdose. This underscores the challenge for congressional leaders as they attempt to tackle this perplexing public health program. Key quote: "These bills are a good step forward, but we need additional focus and resources and investment to really turn the tide of the opioid epidemic," said Rebecca Farley David, vice president of policy and advocacy at the National Council for Behavioral Health. "I think they have taken action on some very important issues." Farley David though has concerns about bills centering around grant-funded initiatives. Grants are needed, but they're time-limited, she said, and more permanent solutions are necessary so the grantees don't have to worry that their funding will get cut off in a few years. Last week: Congress passed 38 bills last week related to the opioid epidemic, mostly with little opposition (Democrats largely opposed three measures). This week: The House plans to consider at least another 19 measures and send a package to the Senate, according to the majority leader's office. Read more here. Bipartisan group of senators target drug shortages. Sens. Chris Murphy (D-Conn.) and Bill Cassidy (R-La.) led 29 of their colleagues in a letter to Food and Drug Administration Commissioner Scott Gottlieb. Their ask: for the agency to convene its Drug Shortages Task Force in an effort to determine the causes behind nationwide shortages and craft policy recommendations on how to fix them, by no later than the end of 2019. What's being affected: There are shortages for some routinely used drugs, making the issue particularly acute. This includes for local anesthetics and sterile IV fluids, the latter of which is used to deliver nearly every drug in an emergency or surgical setting. We have more on the letter here. |
沒有留言:
張貼留言